pharma Sun Pharma Q2 profit: Is it the Worst Outcome Yet? October 30, 2026 Kenneth Bennett Sun Pharma Q2 profit has fallen 36% due to acquisition charges, despite a revenue beat. What does this mean for investors?
pharma Ono Pharmaceutical Excopri Approval: A Clear Positive Change September 26, 2026 Kenneth Bennett Ono Pharmaceutical Excopri approval could change the company's narrative significantly.
pharma Oncology portfolio approvals: Proven benefits for patients September 22, 2026 Kenneth Bennett Oncology portfolio approvals are crucial for advancing treatment options in Azerbaijan.
